In Covid-19

COVID-X is an exclusive acceleration program funded by the European Commission as part of the response plan to defeat COVID-19 with data-driven technology.

The program will grant EU companies [Single Players] with 100K€ in equity-free funding to validate their data solutions in one of the clinical partners from Italy, Spain or Sweden. If the company brings in a Healthcare Provider that can validate the solution [Team Players], the financial support will go up to 150K€ .

The focus will be on clinical challenges related to diagnosis, prognosis or follow-up of COVID-19 patients, or on a new open challenge.

The Open Call#2, running now, will select 15+ top-ranked solutions & the deadline for applications is on 22.07.2021 at 17:00 CEST (Brussels Time).

This is the deadline for the 1st Application Stage validating that the applicants meet the required selection criteria [TRL7+ , CE marking (or in process of) and a solid implementation plan]. Moreover, all selected applications are invited to submit their full proposal in the 2nd Application Stage from early August until the end September.

The selected solutions will join their 10-months acceleration program to boost a quick market uptake. The plan of action will include technical support, ethical validation, and business coaching. In addition, participants deploy the COVID-X Sandbox, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding.

More info: www.covid-x.eu

Applications on F6S platform : www.f6s.com/covid-x/

Contact person at Enterprise Europe Brussels: Emilie Fonck

 

Nieuws in de categorie Bekijk al het nieuws

Data 4 Healthy Recovery Hackathon – last chance to sign up

The new ‘Data 4 Healthy Recovery’ hackathon, taking place from 18 – 20 June, aims to find smart health solutions to help Europe recover from the COVID-19 pandemic stronger and faster, using industrial transformation opportunities in a creative way.

INNO4COV-19: Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance (deadline 30.04.21)

INNO4COV-19 Project aims to provide financial support to companies with the goal of accelerating the development and commercialization of innovative solutions that tackle COVID-19 and that have already been validated in lab environments (TRL6 or higher).

SME survey on supply chain disruption in Europe due to COVID 19

The first results of the SME survey on supply chain disruption in Europe due to COVID 19 are published. Here are the preliminary findings based on 560 responses from 21 member states. • 74% of SMEs were negatively affected by the crisis with supply chain disruptions, employee absences due to sickness or childcare, and production […]

Start typing and press Enter to search